Impact of respiratory infectious epidemics on STEMI incidence and care

Abstract The effect of respiratory infectious diseases on STEMI incidence, but also STEMI care is not well understood. The Influenza 2017/2018 epidemic and the COVID-19 pandemic were chosen as observational periods to investigate the effect of respiratory virus diseases on these outcomes in a metrop...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: S. Macherey, M. M. Meertens, C. Adler, S. Braumann, S. Heyne, T. Tichelbäcker, F. S. Nießen, H. Christ, I. Ahrens, F. M. Baer, F. Eberhardt, M. Horlitz, A. Meissner, J. M. Sinning, S. Baldus, S. Lee
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/ffc9d503b5354414a3ffb7a555fd7af2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ffc9d503b5354414a3ffb7a555fd7af2
record_format dspace
spelling oai:doaj.org-article:ffc9d503b5354414a3ffb7a555fd7af22021-12-05T12:15:45ZImpact of respiratory infectious epidemics on STEMI incidence and care10.1038/s41598-021-02480-z2045-2322https://doaj.org/article/ffc9d503b5354414a3ffb7a555fd7af22021-11-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-02480-zhttps://doaj.org/toc/2045-2322Abstract The effect of respiratory infectious diseases on STEMI incidence, but also STEMI care is not well understood. The Influenza 2017/2018 epidemic and the COVID-19 pandemic were chosen as observational periods to investigate the effect of respiratory virus diseases on these outcomes in a metropolitan area with an established STEMI network. We analyzed data on incidence and care during the COVID-19 pandemic, Influenza 2017/2018 epidemic and corresponding seasonal control periods. Three comparisons were performed: (1) COVID-19 pandemic group versus pandemic control group, (2) COVID-19 pandemic group versus Influenza 2017/2018 epidemic group and (3) Influenza 2017/2018 epidemic group versus epidemic control group. We used Student’s t-test, Fisher’s exact test and Chi square test for statistical analysis. 1455 patients were eligible. The daily STEMI incidence was 1.49 during the COVID-19 pandemic, 1.40 for the pandemic season control period, 1.22 during the Influenza 2017/2018 epidemic and 1.28 during the epidemic season control group. Median symptom-to-contact time was 180 min during the COVID-19 pandemic. In the pandemic season control group it was 90 min (p = 0.183), and in the Influenza 2017/2018 cohort it was 90 min, too (p = 0.216). Interval in the epidemic control group was 79 min (p = 0.733). The COVID-19 group had a door-to-balloon time of 49 min, corresponding intervals were 39 min for the pandemic season group (p = 0.038), 37 min for the Influenza 2017/2018 group (p = 0.421), and 38 min for the epidemic season control group (p = 0.429). In-hospital mortality was 6.1% for the COVID-19 group, 5.9% for the Influenza 2017/2018 group (p = 1.0), 11% and 11.2% for the season control groups. The respiratory virus diseases neither resulted in an overall treatment delay, nor did they cause an increase in STEMI mortality or incidence. The registry analysis demonstrated a prolonged door-to-balloon time during the COVID-19 pandemic.S. MachereyM. M. MeertensC. AdlerS. BraumannS. HeyneT. TichelbäckerF. S. NießenH. ChristI. AhrensF. M. BaerF. EberhardtM. HorlitzA. MeissnerJ. M. SinningS. BaldusS. LeeNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
S. Macherey
M. M. Meertens
C. Adler
S. Braumann
S. Heyne
T. Tichelbäcker
F. S. Nießen
H. Christ
I. Ahrens
F. M. Baer
F. Eberhardt
M. Horlitz
A. Meissner
J. M. Sinning
S. Baldus
S. Lee
Impact of respiratory infectious epidemics on STEMI incidence and care
description Abstract The effect of respiratory infectious diseases on STEMI incidence, but also STEMI care is not well understood. The Influenza 2017/2018 epidemic and the COVID-19 pandemic were chosen as observational periods to investigate the effect of respiratory virus diseases on these outcomes in a metropolitan area with an established STEMI network. We analyzed data on incidence and care during the COVID-19 pandemic, Influenza 2017/2018 epidemic and corresponding seasonal control periods. Three comparisons were performed: (1) COVID-19 pandemic group versus pandemic control group, (2) COVID-19 pandemic group versus Influenza 2017/2018 epidemic group and (3) Influenza 2017/2018 epidemic group versus epidemic control group. We used Student’s t-test, Fisher’s exact test and Chi square test for statistical analysis. 1455 patients were eligible. The daily STEMI incidence was 1.49 during the COVID-19 pandemic, 1.40 for the pandemic season control period, 1.22 during the Influenza 2017/2018 epidemic and 1.28 during the epidemic season control group. Median symptom-to-contact time was 180 min during the COVID-19 pandemic. In the pandemic season control group it was 90 min (p = 0.183), and in the Influenza 2017/2018 cohort it was 90 min, too (p = 0.216). Interval in the epidemic control group was 79 min (p = 0.733). The COVID-19 group had a door-to-balloon time of 49 min, corresponding intervals were 39 min for the pandemic season group (p = 0.038), 37 min for the Influenza 2017/2018 group (p = 0.421), and 38 min for the epidemic season control group (p = 0.429). In-hospital mortality was 6.1% for the COVID-19 group, 5.9% for the Influenza 2017/2018 group (p = 1.0), 11% and 11.2% for the season control groups. The respiratory virus diseases neither resulted in an overall treatment delay, nor did they cause an increase in STEMI mortality or incidence. The registry analysis demonstrated a prolonged door-to-balloon time during the COVID-19 pandemic.
format article
author S. Macherey
M. M. Meertens
C. Adler
S. Braumann
S. Heyne
T. Tichelbäcker
F. S. Nießen
H. Christ
I. Ahrens
F. M. Baer
F. Eberhardt
M. Horlitz
A. Meissner
J. M. Sinning
S. Baldus
S. Lee
author_facet S. Macherey
M. M. Meertens
C. Adler
S. Braumann
S. Heyne
T. Tichelbäcker
F. S. Nießen
H. Christ
I. Ahrens
F. M. Baer
F. Eberhardt
M. Horlitz
A. Meissner
J. M. Sinning
S. Baldus
S. Lee
author_sort S. Macherey
title Impact of respiratory infectious epidemics on STEMI incidence and care
title_short Impact of respiratory infectious epidemics on STEMI incidence and care
title_full Impact of respiratory infectious epidemics on STEMI incidence and care
title_fullStr Impact of respiratory infectious epidemics on STEMI incidence and care
title_full_unstemmed Impact of respiratory infectious epidemics on STEMI incidence and care
title_sort impact of respiratory infectious epidemics on stemi incidence and care
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/ffc9d503b5354414a3ffb7a555fd7af2
work_keys_str_mv AT smacherey impactofrespiratoryinfectiousepidemicsonstemiincidenceandcare
AT mmmeertens impactofrespiratoryinfectiousepidemicsonstemiincidenceandcare
AT cadler impactofrespiratoryinfectiousepidemicsonstemiincidenceandcare
AT sbraumann impactofrespiratoryinfectiousepidemicsonstemiincidenceandcare
AT sheyne impactofrespiratoryinfectiousepidemicsonstemiincidenceandcare
AT ttichelbacker impactofrespiratoryinfectiousepidemicsonstemiincidenceandcare
AT fsnießen impactofrespiratoryinfectiousepidemicsonstemiincidenceandcare
AT hchrist impactofrespiratoryinfectiousepidemicsonstemiincidenceandcare
AT iahrens impactofrespiratoryinfectiousepidemicsonstemiincidenceandcare
AT fmbaer impactofrespiratoryinfectiousepidemicsonstemiincidenceandcare
AT feberhardt impactofrespiratoryinfectiousepidemicsonstemiincidenceandcare
AT mhorlitz impactofrespiratoryinfectiousepidemicsonstemiincidenceandcare
AT ameissner impactofrespiratoryinfectiousepidemicsonstemiincidenceandcare
AT jmsinning impactofrespiratoryinfectiousepidemicsonstemiincidenceandcare
AT sbaldus impactofrespiratoryinfectiousepidemicsonstemiincidenceandcare
AT slee impactofrespiratoryinfectiousepidemicsonstemiincidenceandcare
_version_ 1718372113057841152